Kiora Pharmaceuticals, Inc.
Regulated industryPhysical productsDevelopment stageTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $0.93
- 52-Week Range
- $0.78 – $2.91
- Market Cap
- $3.65M
- P/E (TTM)
- —
- EPS (TTM)
- -2.72
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 0.24
- PEG Ratio
- —
- Return on Equity
- -67.70%
- Return on Assets
- -21.30%
- Gross Margin
- -271.42%
- Operating Margin
- -890.17%
- Profit Margin
- 0.00%
- Current Ratio
- 7.91
- Debt/Equity
- 0.02
- Total Debt
- $286.79K
- Free Cash Flow
- $-4.89M
- Revenue Growth
- —
- Earnings Growth
- —
- Enterprise Value
- $-12.35M
Market Snapshot
About
Kiora Pharmaceuticals is a clinical-stage specialty pharmaceutical company developing therapies for ophthalmic diseases. The company focuses on treating retinal diseases and other sight-threatening eye conditions. Their pipeline includes novel small molecule compounds and drug delivery technologies designed to address significant unmet medical needs in ophthalmology.